PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: LifeSensors, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Cayman Chemical Licenses LifeSensors’ SUMO Platforms Launches New Products - Cayman Chemical Company, Inc. and LifeSensors, Inc. signed a technology license agreement granting Cayman non-exclusive rights to LifeSensors’ protein expression technologies - LifeSensors.com / CaymanChem.com
Cayman Chemical Licenses LifeSensors’ SUMO Platforms Launches New Products

 

NewswireToday - /newswire/ - Malvern, PA, United States, 2011/11/21 - Cayman Chemical Company, Inc. and LifeSensors, Inc. signed a technology license agreement granting Cayman non-exclusive rights to LifeSensors’ protein expression technologies - LifeSensors.com / CaymanChem.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Cayman continues to expand its product line, now utilizing LifeSensors’ protein expression SUMOpro™ and SUMOstar™ platforms. More products are in the pipeline and scheduled for release in coming months. Several thousand Cayman research kits and specialty chemicals are prepared and tested by Cayman in Michigan before being distributed to scientists throughout the world.

Discovered and developed by LifeSensors, Small Ubiquitin-like MOdifier (SUMO) expression systems (1) enhance the quantity of protein by preventing nascent protein degradation; (2) enhance the quality of protein by acting as a nucleation site for proper folding of target proteins; (3) enhance solubility via the hydrophilic C- and N-termini; and (4) facilitate simple purification using SUMO proteases that cleave all junctions to generate native N-termini.

As cost-effective solutions for routine and rare protein production, the scalability of SUMOpro™ and SUMOstar™ platforms also accommodates growth from research grade processes to industrial and commercial manufacturing. By enhancing expression, folding and solubility of recombinant peptides and proteins, SUMO-fusions simplify optimization steps. Scientists are free to optimize their production in prokaryotes and in eukaryotes – both intracellular and secretory cells.

LifeSensors, Inc. (lifesensors.com) develops technologies that utilize SUMO to overcome bottlenecks in protein production. SUMO protein production platforms have been used to manufacture industrial, research and therapeutic proteins. LifeSensors also offers technologies and tools to study the Ubiquitin-Proteasome Pathway. For more information about LifeSensors, visit our website, follow us on Twitter (twitter.com/LifeSensorsInc), call, or email.

Cayman Chemical Company, Inc. (caymanchem.com) is a manufacturer, supplier and vendor of biochemical reagents, assay kits, antibodies and proteins for the advancement of human and veterinary healthcare. With a diverse product line of 4000+ different biochemicals our goal is to "Help Make Research Possible”.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: LifeSensors, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Cayman Chemical Licenses LifeSensors’ SUMO Platforms Launches New Products

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Asim Malik - LifeSensors.com 
610-644-8845 x341 bd[.]lifesensors.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any LifeSensors, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From LifeSensors, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  1Click Games

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)